0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sexually Transmitted Diseases Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Othe-48
Home | Market Reports | Health| Reproductive Health
Global Sexually Transmitted Diseases Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Sexually Transmitted Diseases Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Othe-48
Report
September 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sexually Transmitted Diseases Testing - Market Size

The global market for Sexually Transmitted Diseases Testing was estimated to be worth US$ 74410 million in 2023 and is forecast to a readjusted size of US$ 104270 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Sexually Transmitted Diseases Testing - Market

Sexually Transmitted Diseases Testing - Market

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.
The Americas will be the major revenue contributor to the sexually transmitted diseases testing market owing to the advanced healthcare infrastructure in this region. Also, the increasing awareness about STD testing and the initiatives taken by governments to promote various tests will drive the growth of the STD screening market in this region.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sexually Transmitted Diseases Testing by region & country, by Type, and by Application.
The Sexually Transmitted Diseases Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases Testing.
Market Segmentation

Scope of Sexually Transmitted Diseases Testing - Market Report

Report Metric Details
Report Name Sexually Transmitted Diseases Testing - Market
Forecasted market size in 2030 US$ 104270 million
CAGR 4.5%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Clinics
  • Hospitals
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Qiagen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sexually Transmitted Diseases Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Sexually Transmitted Diseases Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Sexually Transmitted Diseases Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sexually Transmitted Diseases Testing - Market size in 2030?

Ans: The Sexually Transmitted Diseases Testing - Market size in 2030 will be US$ 104270 million.

Who are the main players in the Sexually Transmitted Diseases Testing - Market report?

Ans: The main players in the Sexually Transmitted Diseases Testing - Market are BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Qiagen

What are the Application segmentation covered in the Sexually Transmitted Diseases Testing - Market report?

Ans: The Applications covered in the Sexually Transmitted Diseases Testing - Market report are Clinics, Hospitals, Other

What are the Type segmentation covered in the Sexually Transmitted Diseases Testing - Market report?

Ans: The Types covered in the Sexually Transmitted Diseases Testing - Market report are Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, HIV Testing, HSV Testing, HPV Testing, Chancroid Testing, Other

Recommended Reports

STD Testing & Diagnostics

Infectious Disease Testing

Sexual & Women’s Health

1 Market Overview
1.1 Sexually Transmitted Diseases Testing Product Introduction
1.2 Global Sexually Transmitted Diseases Testing Market Size Forecast
1.3 Sexually Transmitted Diseases Testing Market Trends & Drivers
1.3.1 Sexually Transmitted Diseases Testing Industry Trends
1.3.2 Sexually Transmitted Diseases Testing Market Drivers & Opportunity
1.3.3 Sexually Transmitted Diseases Testing Market Challenges
1.3.4 Sexually Transmitted Diseases Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sexually Transmitted Diseases Testing Players Revenue Ranking (2023)
2.2 Global Sexually Transmitted Diseases Testing Revenue by Company (2019-2024)
2.3 Key Companies Sexually Transmitted Diseases Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sexually Transmitted Diseases Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Sexually Transmitted Diseases Testing
2.6 Sexually Transmitted Diseases Testing Market Competitive Analysis
2.6.1 Sexually Transmitted Diseases Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sexually Transmitted Diseases Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chlamydia Testing
3.1.2 Gonorrhea Testing
3.1.3 Syphilis Testing
3.1.4 HIV Testing
3.1.5 HSV Testing
3.1.6 HPV Testing
3.1.7 Chancroid Testing
3.1.8 Other
3.2 Global Sexually Transmitted Diseases Testing Sales Value by Type
3.2.1 Global Sexually Transmitted Diseases Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sexually Transmitted Diseases Testing Sales Value, by Type (2019-2030)
3.2.3 Global Sexually Transmitted Diseases Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Other
4.2 Global Sexually Transmitted Diseases Testing Sales Value by Application
4.2.1 Global Sexually Transmitted Diseases Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sexually Transmitted Diseases Testing Sales Value, by Application (2019-2030)
4.2.3 Global Sexually Transmitted Diseases Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sexually Transmitted Diseases Testing Sales Value by Region
5.1.1 Global Sexually Transmitted Diseases Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sexually Transmitted Diseases Testing Sales Value by Region (2019-2024)
5.1.3 Global Sexually Transmitted Diseases Testing Sales Value by Region (2025-2030)
5.1.4 Global Sexually Transmitted Diseases Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sexually Transmitted Diseases Testing Sales Value, 2019-2030
5.2.2 North America Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sexually Transmitted Diseases Testing Sales Value, 2019-2030
5.3.2 Europe Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sexually Transmitted Diseases Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sexually Transmitted Diseases Testing Sales Value, 2019-2030
5.5.2 South America Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sexually Transmitted Diseases Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sexually Transmitted Diseases Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sexually Transmitted Diseases Testing Sales Value
6.3 United States
6.3.1 United States Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.3.2 United States Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.4.2 Europe Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.5.2 China Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.6.2 Japan Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.7.2 South Korea Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sexually Transmitted Diseases Testing Sales Value, 2019-2030
6.9.2 India Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sexually Transmitted Diseases Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioMerieux
7.1.1 BioMerieux Profile
7.1.2 BioMerieux Main Business
7.1.3 BioMerieux Sexually Transmitted Diseases Testing Products, Services and Solutions
7.1.4 BioMerieux Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.1.5 BioMerieux Recent Developments
7.2 F. Hoffmann La Roche
7.2.1 F. Hoffmann La Roche Profile
7.2.2 F. Hoffmann La Roche Main Business
7.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Products, Services and Solutions
7.2.4 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.2.5 F. Hoffmann La Roche Recent Developments
7.3 BD
7.3.1 BD Profile
7.3.2 BD Main Business
7.3.3 BD Sexually Transmitted Diseases Testing Products, Services and Solutions
7.3.4 BD Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Abbott Recent Developments
7.4 Abbott
7.4.1 Abbott Profile
7.4.2 Abbott Main Business
7.4.3 Abbott Sexually Transmitted Diseases Testing Products, Services and Solutions
7.4.4 Abbott Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Abbott Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Profile
7.5.2 Bio-Rad Laboratories Main Business
7.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Products, Services and Solutions
7.5.4 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Abbott
7.6.1 Abbott Profile
7.6.2 Abbott Main Business
7.6.3 Abbott Sexually Transmitted Diseases Testing Products, Services and Solutions
7.6.4 Abbott Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Recent Developments
7.7 Qiagen
7.7.1 Qiagen Profile
7.7.2 Qiagen Main Business
7.7.3 Qiagen Sexually Transmitted Diseases Testing Products, Services and Solutions
7.7.4 Qiagen Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Qiagen Recent Developments
8 Industry Chain Analysis
8.1 Sexually Transmitted Diseases Testing Industrial Chain
8.2 Sexually Transmitted Diseases Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sexually Transmitted Diseases Testing Sales Model
8.5.2 Sales Channel
8.5.3 Sexually Transmitted Diseases Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sexually Transmitted Diseases Testing Market Trends
    Table 2. Sexually Transmitted Diseases Testing Market Drivers & Opportunity
    Table 3. Sexually Transmitted Diseases Testing Market Challenges
    Table 4. Sexually Transmitted Diseases Testing Market Restraints
    Table 5. Global Sexually Transmitted Diseases Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sexually Transmitted Diseases Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Sexually Transmitted Diseases Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Sexually Transmitted Diseases Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Sexually Transmitted Diseases Testing
    Table 10. Global Sexually Transmitted Diseases Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Sexually Transmitted Diseases Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Sexually Transmitted Diseases Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Sexually Transmitted Diseases Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Sexually Transmitted Diseases Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Sexually Transmitted Diseases Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Sexually Transmitted Diseases Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Sexually Transmitted Diseases Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Sexually Transmitted Diseases Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Sexually Transmitted Diseases Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Sexually Transmitted Diseases Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Sexually Transmitted Diseases Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Sexually Transmitted Diseases Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Sexually Transmitted Diseases Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Sexually Transmitted Diseases Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Sexually Transmitted Diseases Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Sexually Transmitted Diseases Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Sexually Transmitted Diseases Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Sexually Transmitted Diseases Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioMerieux Basic Information List
    Table 32. BioMerieux Description and Business Overview
    Table 33. BioMerieux Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of BioMerieux (2019-2024)
    Table 35. BioMerieux Recent Developments
    Table 36. F. Hoffmann La Roche Basic Information List
    Table 37. F. Hoffmann La Roche Description and Business Overview
    Table 38. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of F. Hoffmann La Roche (2019-2024)
    Table 40. F. Hoffmann La Roche Recent Developments
    Table 41. BD Basic Information List
    Table 42. BD Description and Business Overview
    Table 43. BD Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of BD (2019-2024)
    Table 45. BD Recent Developments
    Table 46. Abbott Basic Information List
    Table 47. Abbott Description and Business Overview
    Table 48. Abbott Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of Abbott (2019-2024)
    Table 50. Abbott Recent Developments
    Table 51. Bio-Rad Laboratories Basic Information List
    Table 52. Bio-Rad Laboratories Description and Business Overview
    Table 53. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of Bio-Rad Laboratories (2019-2024)
    Table 55. Bio-Rad Laboratories Recent Developments
    Table 56. Abbott Basic Information List
    Table 57. Abbott Description and Business Overview
    Table 58. Abbott Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of Abbott (2019-2024)
    Table 60. Abbott Recent Developments
    Table 61. Qiagen Basic Information List
    Table 62. Qiagen Description and Business Overview
    Table 63. Qiagen Sexually Transmitted Diseases Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Sexually Transmitted Diseases Testing Business of Qiagen (2019-2024)
    Table 65. Qiagen Recent Developments
    Table 66. Key Raw Materials Lists
    Table 67. Raw Materials Key Suppliers Lists
    Table 68. Sexually Transmitted Diseases Testing Downstream Customers
    Table 69. Sexually Transmitted Diseases Testing Distributors List
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
    Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Sexually Transmitted Diseases Testing Product Picture
    Figure 2. Global Sexually Transmitted Diseases Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sexually Transmitted Diseases Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Sexually Transmitted Diseases Testing Report Years Considered
    Figure 5. Global Sexually Transmitted Diseases Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Sexually Transmitted Diseases Testing Revenue in 2023
    Figure 7. Sexually Transmitted Diseases Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chlamydia Testing Picture
    Figure 9. Gonorrhea Testing Picture
    Figure 10. Syphilis Testing Picture
    Figure 11. HIV Testing Picture
    Figure 12. HSV Testing Picture
    Figure 13. HPV Testing Picture
    Figure 14. Chancroid Testing Picture
    Figure 15. Other Picture
    Figure 16. Global Sexually Transmitted Diseases Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Sexually Transmitted Diseases Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Other
    Figure 21. Global Sexually Transmitted Diseases Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Sexually Transmitted Diseases Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America Sexually Transmitted Diseases Testing Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe Sexually Transmitted Diseases Testing Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific Sexually Transmitted Diseases Testing Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America Sexually Transmitted Diseases Testing Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa Sexually Transmitted Diseases Testing Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa Sexually Transmitted Diseases Testing Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions Sexually Transmitted Diseases Testing Sales Value (%), (2019-2030)
    Figure 34. United States Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 40. China Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 42. China Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 52. India Sexually Transmitted Diseases Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India Sexually Transmitted Diseases Testing Sales Value by Type (%), 2023 VS 2030
    Figure 54. India Sexually Transmitted Diseases Testing Sales Value by Application (%), 2023 VS 2030
    Figure 55. Sexually Transmitted Diseases Testing Industrial Chain
    Figure 56. Sexually Transmitted Diseases Testing Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS